DOP074 Adalimumab monotherapy versus combination therapy with adalimumab and immunomodulators for Crohn's disease: A meta-analysis

Authors :: Alain Bitton
Ernest G. Seidman
Talal Al-Taweel
Waqqas Afif
Péter Lakatos
Shomron Ben-Horin
Mohammad Yaghoobi
Uri Kopylov
Source :: Journal of Crohn's and Colitis. 8:S50-S51
Publication Year :: 2014
Publisher :: Oxford University Press (OUP), 2014.

Subjects :: Oncology
medicine.medical_specialty
Crohn's disease
Combination therapy
business.industry
Gastroenterology
General Medicine
medicine.disease
Meta-analysis
Internal medicine
Adalimumab
Medicine
Combined Modality Therapy
Biological response modifiers
business
medicine.drug

Tools